Literature DB >> 19154138

The proline-rich N-terminal sequence of calcineurin Abeta determines substrate binding.

Susann Kilka1, Frank Erdmann, Alexander Migdoll, Gunter Fischer, Matthias Weiwad.   

Abstract

Three different genes of catalytic subunit A of the Ca(2+)-dependent serine/threonine protein phosphatase calcineurin (CaN) are encoded in the human genome forming heterodimers with regulatory subunit B. Even though physiological roles of CaN have been investigated extensively, less is known about the specific functions of the different catalytic isoforms. In this study, all human CaN holoenzymes containing either the alpha, beta, or gamma isoform of the catalytic subunit (CaN alpha, beta, or gamma, respectively) were expressed for the first time. Comparative kinetic analysis of the dephosphorylation of five specific CaN substrates provided evidence that the distinct isoforms of the catalytic subunit confer substrate specificities to the holoenzymes. CaN alpha dephosphorylates the transcription factor Elk-1 with 7- and 2-fold higher catalytic efficiencies than the beta and gamma isoforms, respectively. CaN gamma exhibits the highest k(cat)/K(m) value for DARPP-32, whereas the catalytic efficiencies for the dephosphorylation of NFAT and RII peptide were 3- and 5-fold lower, respectively, when compared with the other isoforms. Elk-1 and NFAT reporter gene activity measurements revealed even more pronounced substrate preferences of CaNA isoforms. Moreover, kinetic analysis demonstrated that CaN beta exhibits for all tested protein substrates the lowest K(m) values. Enzymatic characterization of the CaN beta(P14G/P18G) variant as well as the N-terminal truncated form CaN beta(22-524) revealed that the proline-rich sequence of CaN beta is involved in substrate recognition. CaN beta(22-524) exhibits an at least 4-fold decreased substrate affinity and a 5-fold increased turnover number. Since this study demonstrates that all CaN isoforms display the same cytoplasmic subcellular distribution and are expressed in each tested cell line, differences in substrate specificities may determine specific physiological functions of the distinct isoforms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19154138     DOI: 10.1021/bi8019355

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Calcineurin Aγ is a Functional Phosphatase That Modulates Synaptic Vesicle Endocytosis.

Authors:  Jeffrey R Cottrell; Bing Li; Jae Won Kyung; Crystle J Ashford; James J Mann; Tamas L Horvath; Timothy A Ryan; Sung Hyun Kim; David J Gerber
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

2.  Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland.

Authors:  Ramesh N Reddy; Juan A Pena; Brian R Roberts; Stephen R Williams; S Russ Price; Jennifer L Gooch
Journal:  Am J Pathol       Date:  2011-04       Impact factor: 4.307

Review 3.  Calcineurin signaling in the heart: The importance of time and place.

Authors:  Valentina Parra; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2016-12-20       Impact factor: 5.000

4.  Pan-neuronal knockdown of calcineurin reduces sleep in the fruit fly, Drosophila melanogaster.

Authors:  Jun Tomita; Madoka Mitsuyoshi; Taro Ueno; Yoshinori Aso; Hiromu Tanimoto; Yasuhiro Nakai; Toshiro Aigaki; Shoen Kume; Kazuhiko Kume
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

5.  Calcineurin regulates nuclear factor I dephosphorylation and activity in malignant glioma cell lines.

Authors:  Miranda Brun; Darryl D Glubrecht; Shairaz Baksh; Roseline Godbout
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

6.  Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.

Authors:  Xiaofeng Li; Jinliang Li; Eliana C Martinez; Alexander Froese; Catherine L Passariello; Kathryn Henshaw; Francesca Rusconi; Yang Li; Qian Yu; Hrishikesh Thakur; Viacheslav O Nikolaev; Michael S Kapiloff
Journal:  Circulation       Date:  2020-07-02       Impact factor: 29.690

Review 7.  Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Authors:  Moriah Gildart; Michael S Kapiloff; Kimberly L Dodge-Kafka
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

8.  The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.

Authors:  Frank Erdmann; Matthias Weiwad; Susann Kilka; Magdalena Karanik; Michael Pätzel; Ria Baumgrass; Jürgen Liebscher; Gunter Fischer
Journal:  J Biol Chem       Date:  2009-11-18       Impact factor: 5.157

9.  Cooperative autoinhibition and multi-level activation mechanisms of calcineurin.

Authors:  Sheng-Jie Li; Jue Wang; Lei Ma; Chang Lu; Jie Wang; Jia-Wei Wu; Zhi-Xin Wang
Journal:  Cell Res       Date:  2016-01-22       Impact factor: 25.617

Review 10.  Calcineurin inhibitors: a double-edged sword.

Authors:  Adaku C Ume; Tara-Yesomi Wenegieme; Clintoria R Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.